Connect with us

Technology

ELBIT SYSTEMS REPORTS SECOND QUARTER 2024 RESULTS

Published

on

Order backlog at $21.1 billion; Revenues of $1.6 billion ; Non-GAAP net income of $93 million; GAAP net income of $78 million ; Non-GAAP net EPS of $2.08; GAAP net EPS of $1.76

HAIFA, Israel, Aug. 14, 2024 /PRNewswire/ — Elbit Systems Ltd. (“Elbit Systems” or the “Company”) (NASDAQ: ESLT) (TASE: ESLT), the international high technology defense company, reported today its consolidated results for the second quarter ended June 30, 2024.

In this release, the Company is providing US-GAAP results as well as non-GAAP financial data, which are intended to provide investors a more comprehensive view of the Company’s business results and trends. For a description of the Company’s non-GAAP definitions see page 4 below, “Non-GAAP financial data”. Unless otherwise stated, all financial data presented is US-GAAP financial data.

Management Comment:

Bezhalel (Butzi) Machlis, President and CEO of Elbit Systems, commented:

“Elbit Systems demonstrated a 12% year-over-year increase in revenues in the second quarter. The continuous high demand for our products and solutions reinforces our position as industry leaders. Our long-term investments in technologies, research and development in collaboration with our key customers, and the expansion of our manufacturing capabilities, enable us to meet our commitments to our customers and to drive the continued growth and focus on profitability of the Company, in alignment with our strategic goals. This growth reflects the dedication and commitment of Elbit Systems’ employees in Israel and around the world, who contribute every day to the Company’s success.”

Second quarter 2024 results:

Revenues in the second quarter of 2024 were $1,626.2 million, as compared to $1,453.9 million in the second quarter of 2023.

Aerospace revenues were similar to the revenues in the second quarter of 2023. C4I and Cyber revenues increased by 11% in the second quarter of 2024, as compared to the second quarter of 2023 mainly due to radio systems sales. ISTAR and EW revenues increased by 9% mainly due to Electronic Warfare and Electro-Optic systems sales in Israel and Asia-Pacific. Land revenues increased by 37% due to the increase in ammunition and munition sales in Israel. Elbit Systems of America revenues increased by 11% due to the increase in Maritime and Warfighter systems.

For distribution of revenues by segments and geographic regions see the tables on page 12.

Non-GAAP(*) gross profit amounted to $396.2 million (24.4% of revenues) in the second quarter of 2024, as compared to $379.3 million (26.1% of revenues) in the second quarter of 2023. GAAP gross profit in the second quarter of 2024 was $389.7 million (24.0% of revenues), as compared to $372.2 million (25.6% of revenues) in the second quarter of 2023.

Research and development expenses, net were $116.8 million (7.2% of revenues) in the second quarter of 2024, as compared to $93.4 million (6.4% of revenues) in the second quarter of 2023.

Marketing and selling expenses, net were $87.7 million (5.4% of revenues) in the second quarter of 2024, as compared to $101.7 million (7.0% of revenues) in the second quarter of 2023.

General and administrative expenses, net were $68.7 million (4.2% of revenues) in the second quarter of 2024, as compared to $75.4 million (5.2% of revenues) in the second quarter of 2023.

Non-GAAP(*) operating income was $130.5 million (8.0% of revenues) in the second quarter of 2024, as compared to $115.5 million (7.9% of revenues) in the second quarter of 2023. GAAP operating income in the second quarter of 2024 was $116.5 million (7.2% of revenues), as compared to $101.6 million (7.0% of revenues) in the second quarter of 2023.

Financial expenses, net were $29.1 million in the second quarter of 2024, as compared to $32.1 million in the second quarter of 2023.

Taxes on income were $11.3 million in the second quarter of 2024, as compared to $9.2 million in the second quarter of 2023.

Non-GAAP(*) net income attributable to the Company’s shareholders in the second quarter of 2024 was $92.7 million (5.7% of revenues), as compared to $73.5 million (5.1% of revenues) in the second quarter of 2023. GAAP net income attributable to the Company’s shareholders in the second quarter of 2024 was $78.4 million (4.8% of revenues), as compared to $62.4 million (4.3% of revenues) in the second quarter of 2023.

Non-GAAP(*) diluted net earnings per share attributable to the Company’s shareholders were $2.08 for the second quarter of 2024, as compared to $1.65 for the second quarter of 2023. GAAP diluted earnings per share attributable to the Company’s shareholders in the second quarter of 2024 were $1.76, as compared to $1.40 in the second quarter of 2023.

The Company’s order backlog as of June 30, 2024 totaled $21.1 billion. Approximately 69% of the current backlog is attributable to orders from outside Israel. Approximately 43% of the backlog is scheduled to be performed during the remainder of 2024 and 2025. 

Cash flow provided by operating activities in the six months ended June 30, 2024 was $26.0 million, as compared to cash flow used in operating activities of $210.7 million in the six months ended June 30, 2023. The cash flow in the six months ended June 30, 2024 was affected mainly by the increase in inventories and trade receivables, which was offset by the increase in contract liabilities.

* see page 4

Impact of the “Swords of Iron” War on the Company:

On October 7, 2023, Hamas terrorists infiltrated Israel’s southern border from the Gaza Strip and conducted a series of brutal attacks on civilian and military targets. Hamas also launched extensive rocket attacks on the Israeli population and industrial centers located along Israel’s border with the Gaza Strip and in many other parts of Israel. Israel has also been attacked by other terrorist organizations on different fronts, including from Lebanon, which have prompted military responses from Israel. Following the attacks, the State of Israel declared a state of war, which is ongoing.

Since the commencement of hostilities, Elbit Systems has experienced a material increased demand for our products and solutions from the Israel Ministry of Defense (IMOD) compared to the demand levels prior to the war. We have also increased our support to the IMOD, mainly through deliveries of our systems and the dedicated efforts of our employees. At the same time, the Company continues its activities in the international market including through its local subsidiaries. Subject to further developments, which are difficult to predict, the IMOD’s increased demand for the Company’s products and solutions may continue and could generate material additional orders to the Company.

While the vast majority of our facilities in Israel continue to operate uninterrupted, some of our operations have experienced disruptions due to supply chain and operational constraints, the relocation of certain production lines, evacuation of employees and mobilization of our employees for reserve duty. The number of employees mobilized was approximately 6% as of June 30, 2024, and could fluctuate depending on future developments.

Elbit Systems has taken a number of steps to protect the safety and security of our employees, support our increased production, mitigate potential supply chain disruptions and maintain business continuity, among them relocation of production lines from facilities in areas of the country that have been evacuated to other facilities; recruitment of additional employees; increased monitoring of our global supply chain to identify delays, shortages and bottlenecks; reschedule of deliveries to certain of our customers as necessary; and increase of inventories.

The extent of the effects of the war on the Company’s performance will depend on future developments of the war that are difficult to predict at this time, including its duration and scope. We continue to monitor the situation closely.

* Non-GAAP financial data:

The following non-GAAP financial data, including Adjusted gross profit, Adjusted operating income, Adjusted net income, and Adjusted diluted earnings per share, is presented to enable investors to have additional information on our business performance as well as a further basis for periodical comparisons and trends relating to our financial results. We believe such data provides useful information to investors and analysts by facilitating more meaningful comparisons of our financial results over time. The non-GAAP adjustments exclude amortization expenses of intangible assets related to acquisitions that occurred mainly in prior periods, capital gains related primarily to the sale of investments, restructuring activities, uncompensated costs related to “Swords of Iron” war, non-cash stock based compensation expenses, revaluations of investments in affiliated companies, non-operating foreign exchange gains or losses, one-time tax expenses, and the effect of tax on each of these items. We present these non-GAAP financial measures because management believes they supplement and/or enhance management’s, analysts’ and investors’ overall understanding of the Company’s underlying financial performance and trends and facilitate comparisons among current, past, and future periods.

Specifically, management uses Adjusted gross profit, Adjusted operating income, and Adjusted net income attributable to the Company’s shareholders to measure the ongoing gross profit, operating profit and net income performance of the Company because the measure adjusts for more significant non-recurring items, amortization expenses of intangible assets relating to prior acquisitions, and non-cash expense which can fluctuate year to year.

We believe Adjusted gross profit, Adjusted operating income, and Adjusted net income attributable to the Company’s shareholders are useful to existing shareholders, potential shareholders and other users of our financial information because they provide measures of the Company’s ongoing performance that enable these users to perform trend analysis using comparable data.

Management uses Adjusted diluted earnings per share to evaluate further adjusted net income attributable to the Company’s shareholders while considering changes in the number of diluted shares over comparable periods.

We believe adjusted diluted earnings per share is useful to existing shareholders, potential shareholders and other users of our financial information because it also enables these users to evaluate adjusted net income attributable to Company’s shareholders on a per-share basis.

The non-GAAP measures used by the Company are not based on any comprehensive set of accounting rules or principles. We believe that non-GAAP measures have limitations in that they do not reflect all of the amounts associated with our results of operations, as determined in accordance with GAAP, and that these measures should only be used to evaluate our results of operations in conjunction with the corresponding GAAP measures.

Investors are cautioned that, unlike financial measures prepared in accordance with GAAP, non-GAAP measures may not be comparable with the calculation of similar measures for other companies. They should consider non-GAAP financial measures in addition to, and not as replacements for or superior to, measures of financial performance prepared in accordance with GAAP.

 

Reconciliation of GAAP to Non-GAAP Supplemental Financial Data:

(US Dollars in millions, except for per share amounts)

 
 

Six
months
ended
June 30,
2024

 

Six
months
ended
June 30,
2023

 

Three
months
ended
June 30,
2024

 

Three
months
ended
June 30,
2023

 

Year
ended
December 31,
2023

GAAP gross profit

$     763.8

 

$     733.7

 

$     389.7

 

$     372.2

 

$ 1,483.0

Adjustments:

 
 
 
 
 
 
 
 
 

Amortization of purchased intangible assets(*)

10.6

 

13.6

 

4.2

 

6.6

 

27.3

Restructuring of a subsidiary’s activities

 

 

 

 

17.5

Stock based compensation

0.9

 

1.0

 

0.5

 

0.5

 

1.8

Uncompensated labor costs related to “Swords of Iron” war

4.3

 

 

1.8

 

 

4.3

Non-GAAP gross profit

$     779.6

 

$     748.3

 

$     396.2

 

$     379.3

 

$ 1,533.9

Percent of revenues

24.5 %

 

26.3 %

 

24.4 %

 

26.1 %

 

25.7 %

 
 
 
 
 
 
 
 
 
 

GAAP operating income

$     221.8

 

$     195.5

 

$     116.5

 

$     101.6

 

$     369.1

Adjustments:

 
 
 
 
 
 
 
 
 

Amortization of purchased intangible assets(*)

18.4

 

21.8

 

8.1

 

10.6

 

43.9

Restructuring of a subsidiary’s activities

 

 

 

 

17.5

Stock based compensation

5.7

 

6.8

 

3.3

 

3.3

 

12.1

Uncompensated labor costs related to “Swords of Iron” war

6.2

 

 

2.6

 

 

6.1

Non-GAAP operating income

$     252.1

 

$     224.1

 

$     130.5

 

$     115.5

 

$     448.7

Percent of revenues

7.9 %

 

7.9 %

 

8.0 %

 

7.9 %

 

7.5 %

 
 
 
 
 
 
 
 
 
 

GAAP net income attributable to Elbit Systems’ shareholders

$     152.0

 

$     124.4

 

$       78.4

 

$       62.4

 

$     215.1

Adjustments:

 
 
 
 
 
 
 
 
 

Amortization of purchased intangible assets(*)

18.4

 

21.8

 

8.1

 

10.6

 

43.9

Restructuring of a subsidiary’s activities

 

 

 

 

17.5

Stock based compensation

5.7

 

6.8

 

3.3

 

3.3

 

12.1

Uncompensated labor costs related to “Swords of Iron” war

6.2

 

 

2.6

 

 

6.1

Revaluation of investment measured under fair value option

7.4

 

 

7.4

 

 

3.0

Non-operating foreign exchange (gains) losses

(12.3)

 

2.4

 

(4.9)

 

(1.4)

 

12.0

Tax effect and other tax items, net

(4.0)

 

(2.8)

 

(2.2)

 

(1.4)

 

(10.9)

Non-GAAP net income attributable to Elbit Systems’ shareholders

$     173.4

 

$     152.6

 

$       92.7

 

$       73.5

 

$     298.8

Percent of revenues

5.5 %

 

5.4 %

 

5.7 %

 

5.1 %

 

5.0 %

 
 
 
 
 
 
 
 
 
 

GAAP diluted net EPS

$       3.41

 

$       2.79

 

$       1.76

 

$       1.40

 

$       4.82

Adjustments, net

0.48

 

0.63

 

0.32

 

0.25

 

1.88

Non-GAAP diluted net EPS

$       3.89

 

$       3.42

 

$       2.08

 

$       1.65

 

$       6.70

(*) While amortization of acquired intangible assets is excluded from the measures, the revenue of the acquired companies is reflected in the measures and the acquired assets contribute to revenue generation. 

Recent Events:

On June 10, 2024, the Company announced that S&P Global Ratings Maalot Ltd., an Israeli rating agency (“Maalot”), issued its rating report regarding Elbit Systems (the “Rating Report”). In its Rating Report, Maalot reaffirmed its long term rating of “ilAA” (on local scaling) with a stable outlook regarding the Company’s Series B, C and D Notes, and its short term rating of “ilA-1+” (on local scaling) regarding the Company’s Commercial Paper.  

On July 29, 2024, the Company announced that it was awarded a contract worth approximately $190 million to supply its Iron Sting laser and GPS-guided mortar munition to the Israeli Ministry of Defense. The contract will be performed over a period of two years.

On August 1, 2024, the Company announced that it was awarded a contract in an amount of approximately $340 million for the supply of ammunition to the Israeli Ministry of Defense (IMOD). The contract will be performed over a period of ten years. Elbit Systems will establish a manufacturing facility to produce the ammunition.

On August 6, 2024, the Company announced that it was awarded a contract worth approximately $270 million to supply rocket artillery to an international customer. The contract will be performed over a period of four years.

On August 8, 2024, the Company announced that it was awarded a contract worth approximately $130 million to supply Iron Fist Active Protection Systems to BAE Systems Hägglunds. The systems will be installed on the CV90 Infantry Fighting Vehicle as part of a project of a European country. The contract will be performed over a period of five and a half years.

Dividend:

The Board of Directors declared a dividend of $0.50 per share. The dividend’s record date is October 15, 2024. The dividend will be paid on October 28, 2024, after deduction of withholding tax, at the rate of 16.8%. 

Conference Call:

The Company will be hosting a conference call today, Wednesday, August 14, 2024, at 9:00 a.m. Eastern Time. On the call, management will review and discuss the results and will be available to answer questions.

To participate, please call one of the teleconferencing numbers that follow. If you are unable to connect using the toll-free numbers, please try the international dial-in number.

US Dial-in Number: 1-866-744-5399
Canada Dial-in Number: 1-866-485-2399
Israel Dial-in Number: 03-918-0644
International Dial-in Number: 972-3-918-0644

at 9:00am Eastern Time; 6:00am Pacific Time; 4:00pm Israel Time

The conference call will also be broadcast live on Elbit Systems’ website at https://www.elbitsystems.com. An online replay will be available from 24 hours after the call ends.

Alternatively, for two days following the call, investors will be able to dial a replay number to listen to the call. The dial-in numbers are: 1-888-782-4291 (US and Canada) or +972-3-925-5900 (Israel and International).

About Elbit Systems

Elbit Systems is a leading global defense technology company, delivering advanced solutions for a secure and safer world. Elbit Systems develops, manufactures, integrates and sustains a range of next-generation solutions across multiple domains.

Driven by its agile, collaborative culture, and leveraging Israel’s technology ecosystem, Elbit Systems enables customers to address rapidly evolving battlefield challenges and overcome threats.

Elbit Systems employs over 20,000 people in dozens of countries across five continents. The Company reported as of June 30, 2024 approximately $1.6 billion in revenues and an order backlog of approximately $21.1 billion.

For additional information, visit: https://elbitsystems.com/, follow us on Twitter or visit our official Facebook, Youtube and LinkedIn channels.

Attachments:

Consolidated balance sheets
Consolidated statements of income
Consolidated statements of cash flows
Consolidated revenue distribution by geographical regions and by segments

Company Contact:

Dr. Yaacov (Kobi) Kagan, EVP & Chief Financial Officer

Tel:  +972-77-2946663

kobi.kagan@elbitsystems.com 

 

Dr. David Ravia, Investor Relations

Tel: +972-77-2947169

david.ravia@elbitsystems.com 

 

Dalia Bodinger, VP, Communications & Brand

Tel: +972-77-2947602

dalia.bodinger@elbitsystems.com 

 

This press release may contain forward–looking statements (within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended and the Israeli Securities Law, 1968) regarding Elbit Systems Ltd. and/or its subsidiaries (collectively the Company), to the extent such statements do not relate to historical or current facts. Forward-looking statements are based on management’s current expectations, estimates, projections and assumptions about future events. Forward–looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions about the Company, which are difficult to predict, including projections of the Company’s future financial results, its anticipated growth strategies and anticipated trends in its business. Therefore, actual future results, performance and trends may differ materially from these forward–looking statements due to a variety of factors, including, without limitation: scope and length of customer contracts; governmental regulations and approvals; changes in governmental budgeting priorities; general market, political and economic conditions in the countries in which the Company operates or sells, including Israel and the United States among others; including the duration and scope of the current war in Israel, and the potential impact on our operations; changes in global health and macro-economic conditions; differences in anticipated and actual program performance, including the ability to perform under long-term fixed-price contracts; changes in the competitive environment; and the outcome of legal and/or regulatory proceedings. The factors listed above are not all-inclusive, and further information is contained in Elbit Systems Ltd.’s latest annual report on Form 20-F, which is on file with the U.S. Securities and Exchange Commission. All forward–looking statements speak only as of the date of this release.

Although the Company believes the expectations reflected in the forward-looking statements contained herein are reasonable, it cannot guarantee future results, level of activity, performance or achievements. Moreover, neither the Company nor any other person assumes responsibility for the accuracy and completeness of any of these forward-looking statements. The Company does not undertake to update its forward-looking statements.

Elbit Systems Ltd., its logo, brand, product, service and process names appearing in this Press Release are the trademarks or service marks of Elbit Systems Ltd. or its affiliated companies.  All other brand, product, service and process names appearing are the trademarks of their respective holders.  Reference to or use of a product, service or process other than those of Elbit Systems Ltd. does not imply recommendation, approval, affiliation or sponsorship of that product, service or process by Elbit Systems Ltd. Nothing contained herein shall be construed as conferring by implication, estoppel or otherwise any license or right under any patent, copyright, trademark or other intellectual property right of Elbit Systems Ltd. or any third party, except as expressly granted herein.

(FINANCIAL TABLES TO FOLLOW)

ELBIT SYSTEMS LTD.

CONSOLIDATED BALANCE SHEETS

(In thousands of US Dollars)

 
 

As of

June 30, 2024

 

As of

December 31, 2023

Assets

 
 
 

Cash and cash equivalents

$                  120,662

 

$                    197,429

Short-term bank deposits

18,160

 

10,518

Trade and unbilled receivables and contract assets, net

2,941,362

 

2,716,762

Other receivables and prepaid expenses

317,340

 

285,352

Inventories, net

2,698,651

 

2,298,019

Total current assets

6,096,175

 

5,508,080

 
 
 
 

Investments in affiliated companies and other companies

145,727

 

145,350

Long-term trade and unbilled receivables and contract assets

415,603

 

364,719

Long-term bank deposits and other receivables

80,777

 

87,648

Deferred income taxes, net

23,602

 

23,423

Severance pay fund

195,129

 

206,943

Total

860,838

 

828,083

 
 
 
 

Operating lease right of use assets

526,099

 

425,884

Property, plant and equipment, net

1,173,176

 

1,087,950

Goodwill and other intangible assets, net

1,863,299

 

1,889,585

Total assets

$             10,519,587

 

$                9,739,582

 
 
 
 

Liabilities and Equity

 
 
 

Short-term bank credit and loans

$                  704,285

 

$                    576,594

Current maturities of long-term loans and Series B, C and D Notes

73,364

 

75,286

Operating lease liabilities

72,488

 

67,390

Trade payables

1,276,826

 

1,254,126

Other payables and accrued expenses

1,222,019

 

1,194,347

Contract liabilities

2,058,219

 

1,656,103

Total current liabilities

5,407,201

 

4,823,846

 
 
 
 

Long-term loans, net of current maturities

28,330

 

41,227

Series B, C and D Notes, net of current maturities

272,157

 

342,847

Employee benefit liabilities

485,364

 

510,416

Deferred income taxes and tax liabilities, net

56,967

 

55,240

Contract liabilities

510,379

 

354,319

Operating lease liabilities

449,815

 

363,100

Other long-term liabilities

285,092

 

298,296

Total long-term liabilities

2,088,104

 

1,965,445

 
 
 
 

Elbit Systems Ltd.’s equity

3,021,235

 

2,947,503

Non-controlling interests

3,047

 

2,788

Total equity

3,024,282

 

2,950,291

Total liabilities and equity

$             10,519,587

 

$                9,739,582

 

ELBIT SYSTEMS LTD.

CONSOLIDATED STATEMENTS OF INCOME

(In thousands of US Dollars, except for share and per share amounts)

 
 

Six months
ended June 30, 
2024

 

Six months
ended June 30,
2023

 

Three months
ended June 30, 
2024

 

Three months
ended June 30,
2023

 

Year ended
December 31,
2023

Revenues

$     3,180,108

 

$     2,847,383

 

$     1,626,157

 

$     1,453,895

 

$     5,974,744

Cost of revenues

2,416,274

 

2,113,711

 

1,236,472

 

1,081,739

 

4,491,790

Gross profit

763,834

 

733,672

 

389,685

 

372,156

 

1,482,954

 
 
 
 
 
 
 
 
 
 

Operating expenses:

 
 
 
 
 
 
 
 
 

Research and development, net

215,320

 

203,750

 

116,799

 

93,432

 

424,420

Marketing and selling, net

176,795

 

181,878

 

87,713

 

101,718

 

359,141

General and administrative, net

149,872

 

152,564

 

68,690

 

75,424

 

330,285

Total operating expenses

541,987

 

538,192

 

273,202

 

270,574

 

1,113,846

Operating income

221,847

 

195,480

 

116,483

 

101,582

 

369,108

 
 
 
 
 
 
 
 
 
 

Financial expenses, net

(60,266)

 

(56,269)

 

(29,081)

 

(32,057)

 

(137,827)

Other income (expenses), net

3,267

 

(3,524)

 

(2,029)

 

(1,678)

 

(4,787)

Income before income taxes

164,848

 

135,687

 

85,373

 

67,847

 

226,494

Taxes on income

(22,859)

 

(17,943)

 

(11,261)

 

(9,248)

 

(22,913)

Income after taxes on income

141,989

 

117,744

 

74,112

 

58,599

 

203,581

 
 
 
 
 
 
 
 
 
 

Equity in net earnings of affiliated companies

10,341

 

6,852

 

4,492

 

3,824

 

12,275

 
 
 
 
 
 
 
 
 
 

Net income

$        152,330

 

$        124,596

 

$          78,604

 

$          62,423

 

$        215,856

 
 
 
 
 
 
 
 
 
 

Less: net income attributable to non-controlling interests

(292)

 

(176)

 

(239)

 

(72)

 

(725)

Net income attributable to Elbit Systems Ltd.’s shareholders

$        152,038

 

$        124,420

 

$          78,365

 

$          62,351

 

$        215,131

 
 
 
 
 
 
 
 
 
 

Earnings per share attributable to Elbit Systems Ltd.’s shareholders:

 
 
 
 
 
 
 
 
 

Basic net earnings per share

$               3.42

 

$               2.81

 

$               1.76

 

$               1.41

 

$               4.85

Diluted net earnings per share

$               3.41

 

$               2.79

 

$               1.76

 

$               1.40

 

$               4.82

 
 
 
 
 
 
 
 
 
 

Weighted average number of shares used in computation of:

 
 
 
 
 
 
 
 
 

Basic earnings per share (in thousands)

44,469

 

44,346

 

44,476

 

44,348

 

44,375

Diluted earnings per share (in thousands)

44,641

 

44,548

 

44,623

 

44,637

 

44,592

 

 

ELBIT SYSTEMS LTD.

CONSOLIDATED STATEMENTS OF CASH FLOW

(In thousands of US Dollars)

 
 

Six months
ended June 30,
2024

 

Six months
ended June 30,
2023

 

Year ended
December 31,
2023

CASH FLOWS FROM OPERATING ACTIVITIES

 
 
 
 
 

Net income

$         152,330

 

$         124,596

 

$         215,856

Adjustments to reconcile net income to net cash provided by operating activities:

 
 
 
 
 

Depreciation and amortization

78,122

 

80,735

 

164,799

Stock-based compensation

5,705

 

6,761

 

12,141

Amortization of series B, C and D related issuance costs, net

248

 

311

 

579

Deferred income taxes and reserve, net

6,045

 

(448)

 

(13,165)

Gain on sale of property, plant and equipment

(317)

 

(232)

 

(651)

Loss on sale of investment, remeasurement of investments held under fair value method

7,834

 

 

4,990

Equity in net (earnings) losses of affiliated companies, net of dividend received (*)

(4,999)

 

(1,808)

 

10,046

Changes in operating assets and liabilities, net of amounts acquired:

 
 
 
 
 

Increase in trade and unbilled receivables and prepaid expenses

(300,943)

 

(109,320)

 

(96,594)

Increase in inventories, net

(405,263)

 

(269,281)

 

(351,594)

Increase (decrease) in trade payables and other payables and accrued expenses

(47,845)

 

(43,738)

 

175,446

Severance, pension and termination indemnities, net

(23,272)

 

(13,337)

 

(24,331)

Increase in contract liabilities

558,352

 

15,032

 

16,187

Net cash (used in) provided by operating activities

25,997

 

(210,729)

 

113,709

CASH FLOWS FROM INVESTING ACTIVITIES

 
 
 
 
 

Purchase of property, plant and equipment and other assets

(115,528)

 

(97,237)

 

(187,037)

Acquisition of subsidiaries, net of cash assumed

 

(10,380)

 

(10,380)

Investments in affiliated companies and other companies, net

(1,098)

 

(1,035)

 

(5,416)

Proceeds from sale of property, plant and equipment

4,362

 

590

 

1,466

Proceeds from sale of a subsidiary and an investment

7,376

 

 

151

Investment in short-term deposits, net

(7,591)

 

(25,584)

 

(9,467)

Investment in long-term deposits, net

(441)

 

83

 

83

Net cash used in investing activities

(112,920)

 

(133,563)

 

(210,600)

CASH FLOWS FROM FINANCING ACTIVITIES

 
 
 
 
 

Issuance of shares

6

 

1

 

30

Issuance of commercial paper

36,380

 

 

313,620

Repayment of long-term loans

(11,203)

 

(226,118)

 

(246,231)

Proceeds from long-term bank loans

 

 

20,000

Repayment of Series B, C and D Notes

(61,862)

 

(62,434)

 

(62,434)

Dividends paid (**)

(44,473)

 

(44,857)

 

(89,248)

Change in short-term bank credit and loans, net

91,308

 

578,272

 

147,475

Net cash provided by financing activities

10,156

 

244,864

 

83,212

Net decrease in cash and cash equivalents

(76,767)

 

(99,428)

 

(13,679)

CASH AND CASH EQUIVALENTS AT THE BEGINNING OF THE PERIOD

$         197,429

 

$         211,108

 

$         211,108

CASH AND CASH EQUIVALENTS AT THE END OF THE PERIOD

$         120,662

 

$         111,680

 

$         197,429

(*) Dividend received from affiliated companies and partnerships

$             5,342

 

$             5,044

 

$           22,321

   (**) Dividends paid during 2023 included approximately $0.5 million dividends paid by subsidiaries to non-controlling interests.

 

ELBIT SYSTEMS LTD.

DISTRIBUTION OF REVENUES

(In millions of US Dollars)

Consolidated revenues by geographical regions:

 
 

Six
months
ended
June 30,
2024

 

%

 

Six
months
ended
June 30,
2023

 

%

 

Three
months
ended
June 30,
2024

 

%

 

Three
months
ended
June 30,
2023

 

%

 

Year
ended
December 31,
2023

 

%

Israel

$       896.0

 

28.2

 

$       499.9

 

17.6

 

$       444.0

 

27.3

 

$       244.5

 

16.8

 

$    1,167.2

 

19.5

North America

695.6

 

21.9

 

690.0

 

24.2

 

368.4

 

22.7

 

337.7

 

23.2

 

1,417.7

 

23.7

Europe

857.3

 

27.0

 

832.9

 

29.3

 

472.5

 

29.1

 

464.1

 

31.9

 

1,776.4

 

29.7

Asia-Pacific

542.8

 

17.1

 

653.9

 

23.0

 

235.7

 

14.5

 

315.3

 

21.7

 

1,263.8

 

21.2

Latin America

73.9

 

2.3

 

58.2

 

2.0

 

39.7

 

2.4

 

28.0

 

1.9

 

120.7

 

2.0

Other countries

114.5

 

3.5

 

112.5

 

3.9

 

65.9

 

4.0

 

64.3

 

4.5

 

228.9

 

3.9

Total revenue

$    3,180.1

 

100.0

 

$    2,847.4

 

100.0

 

$    1,626.2

 

100.0

 

$    1,453.9

 

100.0

 

$    5,974.7

 

100.0

 

 

Consolidated revenues by segments:  

 
 

Six months
ended June 30, 
2024

 

Six months
ended June 30,
2023

 

Three months
ended June 30,
2024

 

Three months
ended June 30,
2023

 

Year ended
December 31,
2023

Aerospace

 
 
 
 
 
 
 
 
 

External customers

$               782.2

 

$               784.1

 

$               414.7

 

$               421.9

 

$            1,613.2

Intersegment revenue

120.9

 

123.7

 

66.5

 

65.1

 

260.1

Total

903.1

 

907.8

 

481.2

 

487.0

 

1,873.3

C4I and Cyber

 
 
 
 
 
 
 
 
 

External customers

359.6

 

318.9

 

175.1

 

157.1

 

668.4

Intersegment revenue

25.1

 

25.5

 

12.6

 

11.6

 

52.7

Total

384.7

 

344.4

 

187.7

 

168.7

 

721.1

ISTAR and EW

 
 
 
 
 
 
 
 
 

External customers

561.6

 

492.7

 

264.4

 

243.4

 

996.9

Intersegment revenue

103.3

 

94.7

 

54.4

 

49.3

 

182.5

Total

664.9

 

587.4

 

318.8

 

292.7

 

1,179.4

Land

 
 
 
 
 
 
 
 
 

External customers

741.4

 

554.7

 

380.7

 

276.2

 

1,241.0

Intersegment revenue

41.4

 

40.8

 

22.0

 

17.9

 

65.2

Total

782.8

 

595.5

 

402.7

 

294.1

 

1,306.2

ESA

 
 
 
 
 
 
 
 
 

External customers

735.3

 

697.0

 

391.3

 

355.3

 

1,455.2

Intersegment revenue

1.7

 

3.7

 

1.6

 

 

9.7

Total

737.0

 

700.7

 

392.9

 

355.3

 

1,464.9

Revenues

 
 
 
 
 
 
 
 
 

Total revenues (external customers and intersegment) for reportable segments

3,472.5

 

3,135.8

 

1,783.3

 

1,597.8

 

6,544.9

Less – intersegment revenue

(292.4)

 

(288.4)

 

(157.1)

 

(143.9)

 

(570.2)

Total revenues

$            3,180.1

 

$            2,847.4

 

$            1,626.2

 

$            1,453.9

 

$            5,974.7

 

Logo: https://mma.prnewswire.com/media/2017806/Elbit_Systems_Logo.jpg

 

View original content:https://www.prnewswire.com/news-releases/elbit-systems-reports-second-quarter-2024-results-302222062.html

SOURCE Elbit Systems Ltd.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Insurance Modernization at Risk as Workforce Strategies Fall Behind, Says Info-Tech Research Group

Published

on

By

Insurers are under pressure to modernize core systems while competing for scarce cloud, data, AI, and cybersecurity talent. Info-Tech Research Group’s new blueprint, Rebuild Your Talent Engine: Attract and Retain IT Talent in Insurance, outlines a practical framework to help insurance IT and HR leaders assess readiness, strengthen their employee value proposition, and retain the critical roles needed to accelerate transformation.

ARLINGTON, Va., May 8, 2026 /PRNewswire/ – Insurance modernization is increasingly being constrained by the people and capabilities required to deliver it, according to Info-Tech Research Group. The global research and advisory firm’s newly published blueprint, Rebuild Your Talent Engine: Attract and Retain IT Talent in Insurance, provides a structured approach to help insurers attract, retain, and mobilize the IT talent required to support digital transformation.

The firm’s research indicates that many insurers are trying to advance core system modernization while facing shortages in cloud, data, AI, and cybersecurity roles. At the same time, experienced legacy system experts are retiring, creating knowledge gaps that can slow delivery, increase operational risk, and deepen dependence on external partners.

“Insurance modernization cannot succeed if the workforce strategy behind it remains outdated,” says Vidhi Trivedi, senior research analyst at Info-Tech Research Group. “Insurers need an employee value proposition that reflects what both digital and legacy talent value today: flexibility, growth, purpose, and belonging. When organizations connect those expectations to the technology roadmap, they are better positioned to retain institutional knowledge, attract new capabilities, and move transformation forward with confidence.”

Key Workforce Risks Slowing Insurance Modernization

Info-Tech’s blueprint identifies several talent challenges that are limiting insurers’ ability to modernize effectively:

Critical digital skills remain difficult to attract and retain. Cloud engineers, data architects, cybersecurity specialists, and AI-capable technologists are essential to future-state systems, integration, and automation.Legacy expertise is leaving faster than it can be replaced. Core system knowledge remains vital to operations, compliance, and transition planning, yet many long-tenured experts are approaching retirement or feel disconnected from future-state roles.Rigid work models reduce access to high-demand talent. Digital professionals increasingly expect hybrid options, autonomy, modern delivery practices, and environments that support productivity and wellbeing.Growth pathways are not clearly connected to transformation needs. Without structured upskilling, internal mobility, and role progression, insurers risk losing employees to industries perceived as more innovative or career-accelerating.Employer branding often undersells insurance’s purpose and impact. The industry plays a critical role in protecting people, businesses, and communities, but that purpose is not always translated into a compelling technology career story.

Info-Tech’s Three-Phase Framework for Rebuilding the Insurance IT Talent Engine

To help insurers address these challenges, the Rebuild Your Talent Engine: Attract and Retain IT Talent in Insurance blueprint outlines a three-phase methodology:

Assess Talent Readiness for Modernization Success
Insurance IT and HR leaders identify modernization-critical roles, evaluate workforce pressure, assess EVP fit across key roles, and prioritize the roles that pose the greatest risk to transformation timelines.Build and Embed a Modern Employee Value Proposition
Organizations define a clear employer-employee value exchange, establish proof points across the four EVP pillars of flexibility, growth, purpose, and belonging, and activate targeted initiatives for priority roles.Develop and Present the EVP Impact Report
Leaders synthesize workforce insights, visualize progress, and present a measurable view of how EVP activation is improving retention, engagement, internal mobility, and readiness.

The resource also includes supporting tools, such as the EVP Diagnostic Tool, EVP Activation & Implementation Tool, and EVP Impact Report Template, that help insurers move from talent planning to measurable action.

“Too often, insurers view IT talent challenges as a capacity issue, when they are really a transformation risk,” explains Trivedi. ” “The insurers that move fastest will be those that know where critical capabilities are under strain, protect the expertise that increases operational resilience, and create clear pathways for employees to help shape the future of insurance from within.”

By applying Info-Tech’s framework outlined in the Rebuild Your Talent Engine: Attract and Retain IT Talent in Insurance blueprint, insurance leaders can better understand where people-related risks are highest, strengthen retention in critical roles, reduce long-term reliance on external partners, and build a more resilient technology organization. The firm’s research emphasizes that a modern EVP is not only an HR initiative but a strategic enabler of modernization success.

For exclusive and timely commentary from Info-Tech’s experts, including Vidhi Trivedi, and access to the complete Rebuild Your Talent Engine: Attract and Retain IT Talent in Insurance blueprint, please contact pr@infotech.com.

About Info-Tech Research Group

Info-Tech Research Group is the “get things done” partner for over 30,000 IT, HR, and marketing leaders worldwide. The fastest growing research and advisory firm, Info-Tech enables leaders to make well-informed decisions and transform their organizations through AI, strategic foresight, step-by-step methodologies, practical tools, industry-leading advisory, and training programs. For nearly 30 years, tens of thousands of private and public organizations have trusted Info-Tech to lead their most important initiatives through periods of change and deliver outcomes that truly matter.

To learn more about Info-Tech’s HR research and advisory services, visit McLean & Company, and for data-driven software buying insights and vendor evaluations, visit the firm’s SoftwareReviews platform.

Media professionals can register for unrestricted access to research across IT, HR, and software, and hundreds of industry analysts through the firm’s Media Insiders program. To gain access, contact pr@infotech.com.

For information about Info-Tech Research Group or to access the latest research, visit infotech.com and connect via LinkedIn and X.

View original content to download multimedia:https://www.prnewswire.com/news-releases/insurance-modernization-at-risk-as-workforce-strategies-fall-behind-says-info-tech-research-group-302767354.html

SOURCE Info-Tech Research Group

Continue Reading

Technology

Caris Life Sciences Submits Application to New York State Department of Health for Caris Assure Blood‑Based Testing Authorization

Published

on

By

IRVING, Texas, May 8, 2026 /PRNewswire/ — Caris Life Sciences® (NASDAQ: CAI), a leading patient-centric next-generation AI TechBio company and precision medicine pioneer, today announced that it has submitted an application to the New York State Department of Health (NYSDOH) Clinical Laboratory Evaluation Program (CLEP), administered through the Wadsworth Center, seeking authorization to perform Caris Assure®, its blood‑based molecular profiling test, on specimens originating from New York State.

Caris Assure is a blood‑based molecular profiling test designed to support comprehensive biomarker analysis using a minimally invasive blood sample. Caris Assure uses circulating nucleic acids sequencing (cNAS) to analyze the whole exome (DNA) and whole transcriptome (RNA) of 22,000 genes. This comprehensive test identifies tumor alterations, clonal hematopoiesis (CH) and inherited variants, pharmacogenomic alterations, microsatellite instability (MSI) and tumor mutational burden (TMB).

The submission initiates the formal review process required by New York State for clinical laboratories seeking to perform testing on specimens collected from New York patients. Through the Wadsworth Center, CLEP conducts comprehensive reviews of laboratory permits and laboratory-developed tests to evaluate analytical validation, quality systems, personnel qualifications and compliance with applicable state regulations.

“Caris is committed to meeting the highest standards for laboratory quality, validation and regulatory compliance,” said David Spetzler, MS, PhD, MBA, President of Caris Life Sciences. “This submission of Caris Assure for review through the New York State Department of Health’s Wadsworth Center reflects our disciplined approach to expanding access to our technologies in a manner that demonstrates the rigor, responsibility and focus on the patient that define Caris Life Sciences and guide our work in the markets we serve.”

At this time, no determination has been made by NYSDOH, and Caris Assure is not authorized for use on blood-based specimens originating from New York State unless and until CLEP authorization is granted.

Caris operates a CAP-accredited, CLIA‑certified clinical laboratory and performs testing in jurisdictions where it is authorized to do so, in accordance with all applicable federal, state, and local regulations. Any future availability of Caris Assure in New York State will be contingent upon completion of the CLEP review process administered by the Wadsworth Center and receipt of the appropriate authorization.

About Caris Life Sciences
Caris Life Sciences® (Caris) is a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer actively developing and commercializing innovative solutions to transform healthcare. Through comprehensive molecular profiling (Whole Genome, Whole Exome and Whole Transcriptome Sequencing), advanced AI and machine learning, Caris has created the large-scale, multimodal clinico-genomic database and computing capability needed to analyze and further unravel the molecular complexity of disease. This convergence of next-generation sequencing, AI and machine learning technologies and high-performance computing provides a differentiated platform for developing the latest generation of advanced precision medicine diagnostic solutions for early detection, diagnosis, monitoring, therapy selection and drug development.

Caris was founded with a vision to realize the potential of precision medicine to improve the human condition. Headquartered in Irving, Texas, Caris has offices in Phoenix, New York, Cambridge (MA), Tokyo, Japan and Basel, Switzerland. Caris or its distributor partners provide services in the U.S. and other international markets.

Forward Looking Statements

This press release contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. All statements other than statements of historical facts contained in this press release are forward-looking statements, including statements regarding our business, solutions, plans, objectives, goals, industry trends, financial outlook and guidance. In some cases forward-looking statements can be identified by words such as “may,” “will,” “should,” “would,” “expect,” “plan,” “anticipate,” “could,” “intend,” “target,” “project,” “potential,” “contemplate,” “believe,” “estimate,” “predict,” or “continue” or similar expressions.

You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in these forward-looking statements are reasonable based on information currently available to us, we cannot guarantee that the future results, discoveries, levels of activity, performance or events and circumstances reflected in forward-looking statements will be achieved or occur. Forward-looking statements involve known and unknown risks and uncertainties, some of which are beyond our control. Risks and uncertainties that could cause our actual results to differ materially from those indicated or implied by the forward-looking statements in this press release include, among other things: our future financial performance, results of operations or other operational results or metrics; development, analytical and clinical validation, timing and performance of future solutions by us and our competitors; commercial market acceptance for our solutions, including acceptance of preventive as well as diagnostic testing paradigms, and our ability to meet resulting demand; the rapidly evolving competitive environment in which we operate; third-party payer reimbursement and coverage decisions related to our solutions; risks related to data management, storage, and processing capabilities and our ability to integrate and deploy artificial intelligence and advanced data analytics technologies; our ability to protect and enhance our intellectual property; regulatory requirements, decisions or approvals (including the timing and conditions thereof) related to our solutions, including our application for New York State Department of Health approval for Caris Assure; reliance on third-party suppliers; risks related to data security, patient privacy, and compliance with healthcare data protection regulations as well as potential cybersecurity threats to our data platforms; our compliance with laws and regulations; the outcome of government investigations and litigation; risks related to our indebtedness; and our ability to hire and retain key personnel as well as risks, uncertainties; and other factors described in the section titled “Risk Factors” and elsewhere in our Annual Report on Form 10-K filed on March 3, 2026, and in our other filings we make with the SEC from time to time. We undertake no obligation to update any forward-looking statements to reflect changes in events, circumstances or our beliefs after the date of this press release, except as required by law.

Caris Life Sciences Media:
Corporate Communications
CorpComm@CarisLS.com
214.294.5606 

View original content to download multimedia:https://www.prnewswire.com/news-releases/caris-life-sciences-submits-application-to-new-york-state-department-of-health-for-caris-assure-bloodbased-testing-authorization-302767104.html

SOURCE Caris Life Sciences

Continue Reading

Technology

Dover Declares Regular Quarterly Cash Dividend

Published

on

By

DOWNERS GROVE, Ill., May 8, 2026 /PRNewswire/ — The Board of Directors of Dover Corporation (NYSE: DOV) today declared a regular quarterly cash dividend of $0.52 (fifty-two cents) per share, payable on June 15, 2026, to shareholders of record as of May 29, 2026.

About Dover:

Dover is a diversified global manufacturer and solutions provider with annual revenue of over $8 billion. We deliver innovative equipment and components, consumable supplies, aftermarket parts, software and digital solutions, and support services through five operating segments: Engineered Products, Clean Energy & Fueling, Imaging & Identification, Pumps & Process Solutions and Climate & Sustainability Technologies. Dover combines global scale with operational agility to lead the markets we serve. Recognized for our entrepreneurial approach for over 70 years, our team of approximately 24,000 employees takes an ownership mindset, collaborating with customers to redefine what’s possible. Headquartered in Downers Grove, Illinois, Dover trades on the New York Stock Exchange under “DOV.” Additional information is available at dovercorporation.com.

Investor Contact:

Media Contact:

Jack Dickens
Vice President – Investor Relations
(630) 743-2566
jdickens@dovercorp.com

Adrian Sakowicz
Vice President – Communications
(630) 743-5039
asakowicz@dovercorp.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/dover-declares-regular-quarterly-cash-dividend-302767309.html

SOURCE Dover

Continue Reading

Trending